TMCnet News

Research and Markets: Global Pharmacovigilance Market 2013-2019 - New Opportunities in the $2 Billion Industry
[May 07, 2014]

Research and Markets: Global Pharmacovigilance Market 2013-2019 - New Opportunities in the $2 Billion Industry


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/vw6ddb/pharmacovigilance) has announced the addition of the "Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

The total market for global pharmacovigilance services is estimated to be USD 2,147.3 million in 2012 and is forecast to grow at a CAGR of 12.9% from 2013 to 2019

Some of the major players profiled in this report include PRA International Inc., Covance Inc., Synowledge LLC, OptumInsight Inc., iMedGlobal, TCS, iGATE Corporation, Cognizant (News - Alert) Technology Solutions, Quintiles and others.

Today, pharmacovigilance is considered as a continuous process of evaluation in most of the pharmaceutical companies to reduce the risks associated in bringing the new drug into the market and to improve the safe usage of medicinal products. The proper rules and guidelines for implementation of drug safety monitoring programs has been formulated by various national and international regulatory authorities such as World Health Organization (WHO) and United States Food and Drugs Administration (USFDA).

The global pharmacovigilance market has been segmented based on the type of clinical trials phases, type ofservice providers and type of methods used in drug safety reporting. Based on the type of service providers, the market has been segmented into in-house and contract outsourcing services.



Among these, contract outsourcing services market accounts for the largest market share in 2012 and expected to continue the same till 2019 owing to the high cost of involvement, growing regulatory concerns and requirement of highly qualified professionals for drug safety reporting. Based on type of clinical trials phases, the total market for pharmacovigilance services is categorized into pre-clinical studies, phase I, II, III and IV (post-marketing surveillance services). Among afore-mentioned services, the market for phase IV services accounts for the largest market share in 2012.

Scope


Clinical Trial Phases

  • Pre-Clinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Post-Marketing Surveillance

Service Providers

  • In-House
  • Contract Outsourcing

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Pharmacovigilance Market Dynamics

Chapter 4 Global Pharmacovigilance Market, by Clinical Trial Phases

Chapter 5 Global Pharmacovigilance Market, By Type of Methods

Chapter 6 Global Pharmacovigilance Market, by Type of Service Providers

Chapter 7 Global Pharmacovigilance Market, by Geography

Chapter 8 Global Pharmacovigilance Market Share Analysis

Chapter 9 Recommendations

Chapter 10 Company Profiles

  • Accenture, Plc
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions (News - Alert)
  • Covance, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline (GSK)
  • iGATE Corporation
  • iMEDGlobal Corporation
  • inVentiv Health Inc.
  • ICON, Plc
  • Infosys (News - Alert)
  • Johnson and Johnson
  • Novartis International AG
  • OptumInsight, Inc.
  • PRA International, Inc.
  • Parexel International Corporation
  • Pfizer, Inc.
  • Pharmaceutical Product Development, Inc. (PPD, Inc.)
  • Quantum (News - Alert) Solutions India
  • Quintiles Transnational Corporation
  • Sanofi Aventis
  • Synowledge LLC
  • United BioSource Corporation
  • Wipro (News - Alert) Limited

For more information visit http://www.researchandmarkets.com/research/vw6ddb/pharmacovigilance


[ Back To TMCnet.com's Homepage ]